FHNW - Hochschule für Life Sciences

Medical Additive Manufacturing - implant design, production, material sciences and AM process qualification

Halle 2 / C 2081

Angebot: Dienstleistungsklassen (5)
3D Scannen
Konstruktionsdienstleistungen
Produktentwicklung
Reverse Engineering
Simulation (FEM, Prozesssimulation, etc.)
Weitere Dienstleistungen Entwicklung
Messen, 3D-Scannen
Metallographische Analysen
Mikroskopische Materialanalysen
Weitere Qualitätssicherung
Werkstoffprüfung
Anwendungsentwicklung
Materialentwicklung
Technologieentwicklung
Beratung
Beratung additive Fertigung
Workshops
Kontakte (1)
Foto von M.Eng Daniel Seiler

M.Eng Daniel Seiler

Laborleiter Medical Additive Manufacturing

Über uns
The Institute for Medical and Analytical Technologies (IMA) has a long tradition and expertise in Additive Manufacturing (AM). IMA is a driving force for applied research in AM for MedTech industries and clinics. The institute is well connected throughout Europe and was involved in several European and national funded projects.
IMA runs several Selective Laser Melting machines for metals. Beside testing different metallic materials i.a. NiTi or Magnesium, IMA is running a qualified AM process for the production of titanium implants.
In terms of ceramics IMA is doing research with bone replacing materials like Hydroxyapatite and Tricalcium-Phosphate.
Further on IMA operates different polymer machines, either for UV curable acrylic multi-materials or as extrusion plotters for ABS, PLA, PCLA or laser sintering machines for PA.
Beside this unique AM and process quality expertise, IMA has established complementary knowhow towards Industry 4.0. We are developing novel AM processes and software solutions to shift and distribute design and manufacturing skills to end-users. This allows different industries to develop new business models and new service designs along with AM and digital manufacturing.

The School of Life Sciences FHNW is supporting the interdisciplinary common research on AM related topics. Beside IMA's excellent expertise for AM and its side processes, as described in the paragraph above, we could combine further Life Sciences expertise for AM related topics.
Together with the Institute for Chemistry and Bioanalytics (ICB) and their in-depth knowledge in cell-breeding and bacteria-test labs, we could bring AM structures into pre-clinical biological condition and check their impact on biology.
This widens the portfolio of AM research applications dramatically and ends-up in cell and bacteria processing knowledge which is used to run our latest AM and biomedical research field - 3D Bio-Plotters.
Allgemeine Informationen
http://www.fhnw.ch/hls
Firmengrösse
101-500 Mitarbeiter
Gegründet
2006
Niederlassungen
Muttenz, Schweiz
Hochschule für Life Sciences - FHNW
Kontaktperson: Ralf Schumacher

Gründenstrasse 40
4132 Muttenz

Diese Seite teilen

© Messe Luzern 2017 | Datenschutzrichtlinien